KLP Kapitalforvaltning AS Grows Position in USANA Health Sciences, Inc. (NYSE:USNA)

Key Points

• KLP Kapitalforvaltning AS significantly increased its stake in USANA Health Sciences, acquiring 8,600 additional shares for a total ownership of 10,900 shares, representing a growth of 373.9%.
• USANA Health Sciences reported quarterly earnings of $0.74 EPS, which exceeded analysts' expectations of $0.54, along with revenue of $235.85 million surpassing the consensus estimate.
• Insider trading reports showed that COO Walter Noot and other insiders sold a total of 15,528 shares of USANA stock recently, amounting to $466,513.

KLP Kapitalforvaltning AS increased its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 373.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,900 shares of the company's stock after purchasing an additional 8,600 shares during the period. KLP Kapitalforvaltning AS owned 0.06% of USANA Health Sciences worth $294,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Teacher Retirement System of Texas bought a new stake in USANA Health Sciences in the first quarter worth $888,000. GAMMA Investing LLC boosted its holdings in USANA Health Sciences by 49,082.4% in the first quarter. GAMMA Investing LLC now owns 8,361 shares of the company's stock worth $225,000 after acquiring an additional 8,344 shares in the last quarter. Millennium Management LLC bought a new stake in USANA Health Sciences in the fourth quarter worth $633,000. Exchange Traded Concepts LLC boosted its holdings in USANA Health Sciences by 7.1% in the first quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock worth $248,000 after acquiring an additional 606 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in USANA Health Sciences by 7.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock worth $27,751,000 after acquiring an additional 55,059 shares in the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Stock Performance

Shares of NYSE:USNA traded down $0.54 during midday trading on Friday, reaching $28.85. 166,358 shares of the company's stock traded hands, compared to its average volume of 134,445. The company has a market cap of $537.19 million, a price-to-earnings ratio of 16.03, a P/E/G ratio of 0.93 and a beta of 0.61. USANA Health Sciences, Inc. has a one year low of $23.10 and a one year high of $43.26. The stock has a 50 day moving average of $30.90 and a 200 day moving average of $29.94.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The company reported $0.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.54 by $0.20. The firm had revenue of $235.85 million for the quarter, compared to the consensus estimate of $225.20 million. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%. Sell-side analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised USANA Health Sciences from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,515 shares of the stock in a transaction dated Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total value of $106,363.90. Following the transaction, the insider owned 9,260 shares of the company's stock, valued at approximately $280,207.60. This represents a 27.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Walter Noot sold 6,291 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total value of $190,554.39. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,528 shares of company stock valued at $466,513. 0.63% of the stock is owned by company insiders.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.